WT1 proteins: functions in growth and differentiation

Adachi, 1996, Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1), Oncogene, 13, 2197 Algar, 1996, A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines, Oncogene, 12, 1005 Amin, 1995, Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma, Am. J. Pathol., 146, 344 Armstrong, 1992, The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo, Mech. Dev., 40, 85, 10.1016/0925-4773(93)90090-K Baird, 1992, Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome, Oncogene, 7, 2141 Barbaux, 1997, Donor splice-site mutations in WT1 are responsible for Frasier syndrome, Nat. Genet., 17, 467, 10.1038/ng1297-467 Barbosa, 1999, The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor, Hum. Mutat., 13, 146, 10.1002/(SICI)1098-1004(1999)13:2<146::AID-HUMU7>3.0.CO;2-I Baudry, 2000, WT1 splicing alterations in Wilms' tumors, Clin. Cancer Res., 6, 3957 Bickmore, 1989, CpG islands surround a DNA segment located between translocation breakpoints associated with genitourinary dysplasia and aniridia, Genomics, 5, 685, 10.1016/0888-7543(89)90109-2 Bickmore, 1992, Modulation of DNA binding specificity by alternative splicing of the Wilms' tumor WT1 gene transcript, Science, 257, 235, 10.1126/science.1321494 Brown, 1992, Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient, Oncogene, 7, 763 Bruening, 1996, A non-AUG translational initiation event generates novel WT1 isoforms, J. Biol. Chem., 271, 8646, 10.1074/jbc.271.15.8646 Bruening, 1996, Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product, FEBS Lett., 393, 41, 10.1016/0014-5793(96)00853-8 Call, 1990, Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus, Cell, 60, 509, 10.1016/0092-8674(90)90601-A Caricasole, 1996, RNA binding by the Wilms' tumor suppressor zinc finger proteins, Proc. Natl. Acad. Sci. USA, 93, 7562, 10.1073/pnas.93.15.7562 Carrington, 2000, Overexpression of murine WT1 +/+ and −/− isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line, Leuk. Res., 24, 927, 10.1016/S0145-2126(00)00064-3 Cook, 1996, Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1, Oncogene, 13, 1789 Davies, 1998, WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes, Genes Dev., 12, 3217, 10.1101/gad.12.20.3217 Dechsukhum, 2000, Detection of a novel truncated WT1 transcript in human neoplasia, Mol. Diagn., 5, 117, 10.2165/00066982-200005020-00005 Dehbi, 1996, PAX8-mediated activation of the WT1 tumor suppressor gene, EMBO J., 15, 4297, 10.1002/j.1460-2075.1996.tb00804.x Dehbi, 1996, The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1), Oncogene, 13, 447 Dejong, 1999, The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun, Oncogene, 18, 3143, 10.1038/sj.onc.1202654 Deuel, 1999, Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain, Biochem. Biophys. Res. Commun., 254, 192, 10.1006/bbrc.1998.9896 Dey, 1994, Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product, Mol. Endocrinol., 8, 595, 10.1210/me.8.5.595 Diaz-Meco, 1996, The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C, Cell, 86, 777, 10.1016/S0092-8674(00)80152-X Donehower, 1992, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours, Nature, 356, 215, 10.1038/356215a0 Donovan, 1999, Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud, Dev. Genet., 24, 252, 10.1002/(SICI)1520-6408(1999)24:3/4<252::AID-DVG8>3.0.CO;2-K Drummond, 1992, Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1, Science, 257, 674, 10.1126/science.1323141 Drummond, 1994, DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1, Mol. Cell. Biol., 14, 3800, 10.1128/MCB.14.6.3800 Duarte, 1998, Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype, Br. J. Cancer, 77, 253, 10.1038/bjc.1998.41 Englert, 1995, WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis, EMBO J., 14, 4662, 10.1002/j.1460-2075.1995.tb00148.x Englert, 1995, Truncated WT1 mutants alter the subnuclear localization of the wild-type protein, Proc. Natl. Acad. Sci. USA, 92, 11960, 10.1073/pnas.92.26.11960 Englert, 1997, Induction of p21 by the Wilms' tumor suppressor gene WT1, Cancer Res., 57, 1429 English, 1999, Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control, J. Biol. Chem., 274, 13258, 10.1074/jbc.274.19.13258 Ernstsson, 1996, Characterization of the human forkhead gene FREAC-4 – evidence for regulation by Wilms' tumor suppressor gene (WT-1) and p53, J. Biol. Chem., 271, 21094, 10.1074/jbc.271.35.21094 Fantes, 1992, Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization, Am. J. Hum. Genet., 51, 1286 Fraizer, 1995, Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow, Blood, 86, 4704, 10.1182/blood.V86.12.4704.bloodjournal86124704 Fraizer, 1997, PAX 8 regulates human WT1 transcription through a novel DNA binding site, J. Biol. Chem., 272, 30678, 10.1074/jbc.272.49.30678 Francke, 1979, Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13, Cytogenet. Cell Genet., 24, 185, 10.1159/000131375 Gashler, 1992, Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1, Proc. Natl. Acad. Sci. USA, 89, 10984, 10.1073/pnas.89.22.10984 Gerald, 1995, Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor, Proc. Natl. Acad. Sci. USA, 92, 1028, 10.1073/pnas.92.4.1028 Gessler, 1990, Homozygous deletion in Wilms' tumours of a gene identified by chromosome jumping, Nature, 343, 774, 10.1038/343774a0 Gessler, 1992, The genomic organization and expression of the WT1 gene, Genomics, 12, 807, 10.1016/0888-7543(92)90313-H Gessler, 1993, Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome, Genes Chromosomes Cancer, 7, 131, 10.1002/gcc.2870070304 Gessler, 1994, Infrequent mutation of the WT1 gene in 77 Wilms' tumors, Hum. Mutat., 3, 212, 10.1002/humu.1380030307 Glaser, 1989, A highly polymorphic locus cloned from the breakpoint of a chromosome 11p13 deletion associated with the WAGR syndrome, Genomics, 5, 880, 10.1016/0888-7543(89)90130-4 Goodyer, 1995, Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, WT1, Oncogene, 10, 1125 Grundy, 1988, Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11, Nature, 336, 374, 10.1038/336374a0 Guan, 1998, Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition, J. Biol. Chem., 273, 27047, 10.1074/jbc.273.42.27047 Haber, 1991, Alternative splicing and genomic structure of the Wilms' tumor gene WT1, Proc. Natl. Acad. Sci. USA, 88, 9618, 10.1073/pnas.88.21.9618 Haber, 1993, WT1-mediated growth suppression of Wilms' tumor cells expressing a WT1 splicing variant, Science, 262, 2057, 10.1126/science.8266105 Hamilton, 1995, High affinity binding sites for the Wilms' tumour suppressor protein WT1, Nucleic Acids Res., 23, 277, 10.1093/nar/23.2.277 Harrington, 1993, Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus, J. Biol. Chem., 268, 21271, 10.1016/S0021-9258(19)36920-0 Hastie, 1994, The genetics of Wilms' tumor – a case of disrupted development, Annu. Rev. Genet., 28, 523, 10.1146/annurev.ge.28.120194.002515 Herzer, 1999, The Wilms' tumor suppressor gene WT1 is required for development of the spleen, Curr. Biol., 12, 837, 10.1016/S0960-9822(99)80369-8 Hewitt, 1995, Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1, Cancer Res., 55, 5386 Hewitt, 1996, Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation, J. Biol. Chem., 271, 8588, 10.1074/jbc.271.15.8588 Hofmann, 1993, Characterization of the transcriptional regulatory region of the human WT1 gene, Oncogene, 8, 3123 Holmes, 1997, Two N-terminal self-association domains are required for the dominant negative transcriptional activity of WT1 Denys-Drash mutant proteins, Biochem. Biophys. Res. Commun., 233, 723, 10.1006/bbrc.1997.6545 Hosono, 1999, WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts, Oncogene, 18, 417, 10.1038/sj.onc.1202311 Hosono, 2000, E-cadherin is a WT1 target gene, J. Biol. Chem., 275, 10943, 10.1074/jbc.275.15.10943 Hossain, 2001, The human sex-determining gene SRY is a direct target of WT1, J. Biol. Chem., 276, 16817, 10.1074/jbc.M009056200 Hsu, 1995, Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter, Mol. Endocrinol., 9, 1356, 10.1210/me.9.10.1356 Inoue, 1994, WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia, Blood, 84, 3071, 10.1182/blood.V84.9.3071.3071 Inoue, 1998, Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells, Blood, 91, 2969, 10.1182/blood.V91.8.2969.2969_2969_2976 Jadresic, 1990, Clinicopathologic review of twelve children with nephropathy, Wilms' tumor, and genital abnormalities (Drash syndrome), J. Pediatr., 117, 717, 10.1016/S0022-3476(05)83327-X Johnstone, 1996, A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1, Mol. Cell. Biol., 16, 6945, 10.1128/MCB.16.12.6945 Johnstone, 1998, Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1, J. Biol. Chem., 273, 10880, 10.1074/jbc.273.18.10880 Kaghad, 1997, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, 90, 809, 10.1016/S0092-8674(00)80540-1 Karnieli, 1996, The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein, J. Biol. Chem., 271, 19304, 10.1074/jbc.271.32.19304 Kennedy, 1996, An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling, Nat. Genet., 12, 329, 10.1038/ng0396-329 Kent, 1995, The evolution of WT1 sequence and expression pattern in the vertebrates, Oncogene, 11, 1781 Kikuchi, 1998, Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?, J. Med. Genet., 35, 45, 10.1136/jmg.35.1.45 Kim, 1998, The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties, Oncogene, 16, 1973, 10.1038/sj.onc.1201716 Kim, 1999, The Wilms' tumor suppressor gene (WT1) product regulates Dax-1 gene expression during gonadal differentiation, Mol. Cell. Biol., 19, 2289, 10.1128/MCB.19.3.2289 Kinane, 1994, Growth of LLC-PK1 renal cells is mediated by EGR-1 up-regulation of G protein alpha i-2 protooncogene transcription, J. Biol. Chem., 269, 27503, 10.1016/S0021-9258(18)47013-5 Kinane, 1996, LLC-PK1 cell growth is repressed by WT1 inhibition of G-protein alpha i-2 protooncogene transcription, J. Biol. Chem., 270, 30760, 10.1074/jbc.270.51.30760 King-Underwood, 1998, Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance, Blood, 91, 2961, 10.1182/blood.V91.8.2961.2961_2961_2968 King-Underwood, 1996, Mutations in the Wilms' tumor gene WT1 in leukemias, Blood, 87, 2171, 10.1182/blood.V87.6.2171.bloodjournal8762171 Klamt, 1998, Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/−KTS splice isoforms, Hum. Mol. Genet., 7, 709, 10.1093/hmg/7.4.709 Kleinebrecht, 1982, The mouse mutant limb-deformity (ld), Anat. Anz., 152, 313 Koehler, 2000, Hox11 is required to maintain normal Wt1 mRNA levels in the developing spleen, Dev. Dyn., 218, 201, 10.1002/(SICI)1097-0177(200005)218:1<201::AID-DVDY18>3.0.CO;2-R Kohsaka, 1999, Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier Syndrome, Hum. Mutat., 14, 466, 10.1002/(SICI)1098-1004(199912)14:6<466::AID-HUMU4>3.0.CO;2-6 Koufos, 1989, Familial Wiedemann-Beckwith syndrome and a second Wilms' tumor locus both map to 11p15.5, Am. J. Hum. Genet., 44, 711 Kreidberg, 1993, WT-1 is required for early kidney development, Cell, 74, 679, 10.1016/0092-8674(93)90515-R Kudoh, 1996, Constitutive expression of the Wilms' tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid, Oncogene, 13, 1431 Kumar-Singh, 1997, WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis, J. Pathol., 181, 67, 10.1002/(SICI)1096-9896(199701)181:1<67::AID-PATH723>3.0.CO;2-Z Ladanyi, 1994, Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor, Cancer Res., 54, 2837 Ladomery, 1999, Presence of WT1, the Wilms' tumor suppressor gene product, in nuclear poly(A)+ ribonucleoprotein, J. Biol. Chem., 274, 36520, 10.1074/jbc.274.51.36520 Laity, 2000, Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformation changes, Biochemistry, 39, 5341, 10.1021/bi9926678 Laity, 2000, Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein, Proc. Natl. Acad. Sci. USA, 97, 11932, 10.1073/pnas.97.22.11932 Larsson, 1995, Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing, Cell, 81, 391, 10.1016/0092-8674(95)90392-5 Lee, 1997, The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour, Nat. Genet., 17, 309, 10.1038/ng1197-309 Lee, 1999, The Wilms' tumor suppressor WT1 encodes a transcriptional activator of amphiregulin, Cell, 98, 663, 10.1016/S0092-8674(00)80053-7 Lee, 1996, Transcriptional repression of human insulin-like growth factor-II p4 promoter by Wilms' tumor suppressor WT1, DNA Cell Biol., 15, 99, 10.1089/dna.1996.15.99 Little, 1997, A clinical overview of WT1 gene mutations, Hum. Mutat., 9, 209, 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2 Little, 1992, Zinc finger point mutations within the WT1 gene in Wilms' tumor patients, Proc. Natl. Acad. Sci. USA, 89, 4791, 10.1073/pnas.89.11.4791 Little, 1993, Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion, Hum. Mol. Genet., 2, 259, 10.1093/hmg/2.3.259 Little, 2000, Identification of WTAP, a novel Wilms' tumour 1-associating protein, Hum. Mol. Genet., 9, 2231, 10.1093/oxfordjournals.hmg.a018914 Liu, 1999, Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor, Biochem. Biophys. Res. Commun., 254, 197, 10.1006/bbrc.1998.9897 Liu, 2000, Cloning and characterization of the promoter region of the rat epidermal growth factor receptor gene and its transcriptional regulation by nerve growth factor in PC12 cells, J. Biol. Chem., 275, 7280, 10.1074/jbc.275.10.7280 Liu, 2001, The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells, J. Biol. Chem., 276, 5068, 10.1074/jbc.M008776200 Luetteke, 1999, Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles of the EGF receptor ligands in mouse mammary gland development, Development, 126, 2739, 10.1242/dev.126.12.2739 Luo, 1995, The tumor suppressor gene WT1 inhibits ras-mediated transformation, Oncogene, 11, 743 Machin, 1984, A new precursor lesion of Wilms' tumour (nephroblastoma): intralobar multifocal nephroblastomatosis, Histopathology, 8, 35, 10.1111/j.1365-2559.1984.tb02320.x Madden, 1991, Transcriptional repression mediated by the WT1 Wilms' tumor gene product, Science, 253, 1550, 10.1126/science.1654597 Maheswaran, 1993, Physical and functional interaction between WT1 and p53 proteins, Proc. Natl. Acad. Sci. USA, 90, 5100, 10.1073/pnas.90.11.5100 Maheswaran, 1995, The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis, Genes Dev., 9, 2143, 10.1101/gad.9.17.2143 Maheswaran, 1998, Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 requires association with the inducible chaperone Hsp70, Genes Dev., 12, 1108, 10.1101/gad.12.8.1108 Malik, 1994, Autoregulation of the human WT1 gene promoter, FEBS Lett., 349, 75, 10.1016/0014-5793(94)00642-3 Marin, 2000, p63 and p73: old members of a new family, Biochim. Biophys. Acta, 1470, M93 Martinerie, 1996, Regulation of nov by WT1: a potential role for nov in nephrogenesis, Oncogene, 12, 1479 Mattaj, 1994, RNA processing. Splicing in space, Nature, 372, 727, 10.1038/372727a0 Mayo, 1999, WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene, EMBO J., 18, 3990, 10.1093/emboj/18.14.3990 McCann, 1995, Repression of the c-myb gene by WT1 protein in T and B cell lines, J. Biol. Chem., 270, 23785, 10.1074/jbc.270.40.23785 McConnell, 1997, Differential regulation of the human Wilms' tumour suppressor gene (WT1) promoter by two isoforms of PAX2, Oncogene, 14, 2689, 10.1038/sj.onc.1201114 McCoy, 1999, The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter, Cell Growth Differ., 10, 377 McElreavey, 1999, Sex determination and the Y chromosome, Am. J. Med. Genet., 89, 176, 10.1002/(SICI)1096-8628(19991229)89:4<176::AID-AJMG2>3.0.CO;2-B McMaster, 1995, WT1 expression alters tumorigenicity of the G401 kidney-derived cell line, Cell Growth Differ., 6, 1609 Menke, 1995, Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: involvement of the Wilms' tumor 1 gene, Int. J. Cancer, 63, 76, 10.1002/ijc.2910630115 Menke, 1996, Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells, Oncogene, 12, 537 Menke, 1997, Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor, Cancer Res., 57, 1353 Menke, 1998, The Wilms' tumor 1 gene: oncogene or tumor suppressor gene?, Int. Rev. Cytol., 181, 151, 10.1016/S0074-7696(08)60418-0 Mills, 1999, p63 is a p53 homologue required for limb and epidermal morphogenesis, Nature, 398, 708, 10.1038/19531 Minc, 1999, The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1 and WT1 via non-canonical binding sites, J. Biol. Chem., 274, 503, 10.1074/jbc.274.1.503 Misteli, 1997, The dynamics of a pre-mRNA splicing factor in living cells, Nature, 387, 523, 10.1038/387523a0 Miyagawa, 1998, Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour, Nat. Genet., 18, 15, 10.1038/ng0198-15 Moore, 1998, YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb, Mech. Dev., 79, 169, 10.1016/S0925-4773(98)00188-9 Moore, 1999, YAC complementation shows a requirement for WT1 in the development of epicardium, adrenal gland and throughout nephrogenesis, Development, 126, 1845, 10.1242/dev.126.9.1845 Morris, 1991, Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus, Oncogene, 6, 2339 Moshier, 1996, Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1, Nucleic Acids Res., 24, 1149, 10.1093/nar/24.6.1149 Mrowka, 2000, Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features, J. Am. Soc. Nephrol., 11, S106, 10.1681/ASN.V11suppl_2s106 Murata, 1997, The Wilms' tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells, FEBS Lett., 409, 41, 10.1016/S0014-5793(97)00477-8 Muscatelli, 1994, Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, Nature, 372, 672, 10.1038/372672a0 Nachtigal, 1998, Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression, Cell, 93, 445, 10.1016/S0092-8674(00)81172-1 Nakagama, 1995, Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product, Mol. Cell. Biol., 15, 1489, 10.1128/MCB.15.3.1489 Nichols, 1995, WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells, Cancer Res., 55, 4540 Novack, 1994, Bcl-2 protein expression during murine development, Am. J. Pathol., 145, 61 Oh, 1999, The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene, J. Biol. Chem., 274, 37473, 10.1074/jbc.274.52.37473 Osada, 1998, Cloning and functional analysis of human p51, which structurally and functionally resembles p53, Nat. Med., 4, 839, 10.1038/nm0798-839 Park, 1993, The Wilms' tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma, Nat. Genet., 4, 415, 10.1038/ng0893-415 Park, 1993, Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour, Nat. Genet., 5, 363, 10.1038/ng1293-363 Parker, 1999, Gene interactions in gonadal development, Annu. Rev. Physiol., 61, 417, 10.1146/annurev.physiol.61.1.417 Parker, 1999, Genes essential for early events in gonadal development, Cell. Mol. Life Sci., 55, 831, 10.1007/s000180050337 Patek, 1999, A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome, Proc. Natl. Acad. Sci. USA, 96, 2931, 10.1073/pnas.96.6.2931 Patmasiriwat, 1996, Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities, Leukemia, 10, 1127 Pelletier, 1991, Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome, Cell, 67, 437, 10.1016/0092-8674(91)90194-4 Pelletier, 1991, WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour, Nature, 353, 431, 10.1038/353431a0 Pelletier, 1991, Expression of the Wilms' tumor gene WT1 in the murine urogenital system, Genes Dev., 5, 1345, 10.1101/gad.5.8.1345 Phelan, 1994, Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells, Cell Growth Differ., 5, 677 Pritchard-Jones, 1997, The Wilms' tumour gene WT1 in leukaemia, Leukemia Lymphoma, 27, 207, 10.3109/10428199709059677 Pritchard-Jones, 1990, The candidate Wilms' tumour gene is involved in genitourinary development, Nature, 346, 194, 10.1038/346194a0 Pritchard-Jones, 1994, The Wilms' tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient, Hum. Mol. Genet., 3, 1633, 10.1093/hmg/3.9.1633 Rackley, 1993, Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis, Cell Growth Differ., 4, 1023 Rackley, 1995, In situ expression of the early growth response gene-1 during murine nephrogenesis, J. Urol., 154, 700, 10.1016/S0022-5347(01)67136-2 Rahman, 1996, Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21, Nat. Genet., 13, 461, 10.1038/ng0896-461 Rahman, 1997, The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene, Oncogene, 14, 3099, 10.1038/sj.onc.1201107 Rauscher, 1993, The WT1 Wilms' tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor, Fed. Am. Soc. Exp. Biol. J., 7, 896 Rauscher, 1990, Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence, Science, 250, 1259, 10.1126/science.2244209 Reddy, 1995, WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins, J. Biol. Chem., 270, 10878, 10.1074/jbc.270.18.10878 Reddy, 1995, The transcriptional effect of WT1 is modulated by choice of expression vector, J. Biol. Chem., 270, 29976, 10.1074/jbc.270.50.29976 Reeve, 1989, Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells, Mol. Cell. Biol., 9, 1799, 10.1128/MCB.9.4.1799 Renshaw, 1997, Differential splicing of exon 5 of the Wilms' tumour (WTI) gene, Genes Chromosomes Cancer, 19, 256, 10.1002/(SICI)1098-2264(199708)19:4<256::AID-GCC8>3.0.CO;2-W Richard, 2001, Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1, Genes Dev., 15, 328, 10.1101/gad.185901 Rupprecht, 1994, The Wilms' tumor suppressor gene WT1 is negatively autoregulated, J. Biol. Chem., 269, 6198, 10.1016/S0021-9258(17)37588-9 Ryan, 1995, Repression of Pax-2 by WT1 during normal kidney development, Development, 121, 867, 10.1242/dev.121.3.867 Sakamoto, 1997, Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of ser-365 and ser-393 in the zinc finger domain, Oncogene, 15, 2001, 10.1038/sj.onc.1201391 Saxen, 1987, Early organogenesis of the kidney, Pediatr. Nephrol., 1, 385, 10.1007/BF00849241 Scharnhorst, 1997, Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells, Cell Growth Differ., 8, 133 Scharnhorst, 1999, Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties, J. Biol. Chem., 274, 23456, 10.1074/jbc.274.33.23456 Scharnhorst, 2000, EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene product on tumorigenicity, Oncogene, 19, 791, 10.1038/sj.onc.1203390 Scharnhorst, 2000, Physical interaction between WT1 and p73 proteins modulates their functions, J. Biol. Chem., 275, 10202, 10.1074/jbc.275.14.10202 Schedl, 2000, Cross-talk in kidney development, Curr. Opin. Genet. Dev., 10, 543, 10.1016/S0959-437X(00)00125-8 Schmale, 1997, A novel protein with strong homology to the tumor suppressor p53, Oncogene, 15, 1363, 10.1038/sj.onc.1201500 Sekiya, 1994, Downregulation of Wilms' tumor gene (WT1) during myelomonocytic differentiation in HL60 cells, Blood, 83, 1876, 10.1182/blood.V83.7.1876.1876 Sells, 1994, Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells, Cell Growth Differ., 5, 457 Sells, 1997, Expression and function of the leucine zipper protein Par-4 in apoptosis, Mol. Cell. Biol., 17, 3823, 10.1128/MCB.17.7.3823 Sharma, 1992, Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain, Cancer Res., 52, 6407 Sharma, 1994, RNA editing in the Wilms' tumor susceptibility gene, WT1, Genes Dev., 8, 720, 10.1101/gad.8.6.720 Shen, 1994, Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade, Cell, 77, 651, 10.1016/0092-8674(94)90050-7 Slater, 1992, Cytogenetics and molecular genetics of Wilms' tumor of childhood, Cancer Genet. Cytogenet., 61, 111, 10.1016/0165-4608(92)90071-F Smith, 1998, Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells, Blood, 91, 764, 10.1182/blood.V91.3.764 Smith, 2000, Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice, Cancer Res., 60, 808 Stanhope-Baker, 2000, Identification of connective tissue growth factor as a target of WT1 transcriptional regulation, J. Biol. Chem., 275, 38139, 10.1074/jbc.M004901200 Svedberg, 1998, Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program, Oncogene, 16, 925, 10.1038/sj.onc.1201613 Svedberg, 1999, Downregulation of Wilms' tumor gene (WT1) is not a prerequisite for erythroid or megakaryocytic differentiation of the leukemic cell line K562, Exp. Hematol., 27, 1057, 10.1016/S0301-472X(99)00038-7 Tajinda, 1999, Regulation of the insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor, Endocrinology, 140, 4713, 10.1210/en.140.10.4713 Tamaki, 1999, The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes, Leukemia, 13, 393, 10.1038/sj.leu.2401341 Torban, 1998, Effects of PAX2 expression in a human fetal kidney (HEK293) cell line, Biochim. Biophys. Acta, 1401, 53, 10.1016/S0167-4889(97)00119-5 Trink, 1998, A new human p53 homologue, Nat. Med., 4, 747, 10.1038/nm0798-747 Wang, 1992, The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene, J. Biol. Chem., 267, 21999, 10.1016/S0021-9258(18)41624-9 Wang, 1993, The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains, J. Biol. Chem., 268, 9172, 10.1016/S0021-9258(18)98329-8 Wang, 1993, A second transcriptionally active DNA-binding site for the Wilms' tumor gene product, WT1, Proc. Natl. Acad. Sci. USA, 90, 8896, 10.1073/pnas.90.19.8896 Wang, 1995, Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, WT1, have altered DNA binding specificity and regulate transcription in different ways, Oncogene, 10, 415 Wang, 1995, WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein, Oncogene, 10, 1243 Wang, 1996, Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9, J. Biol. Chem., 271, 24811, 10.1074/jbc.271.40.24811 Ward, 1995, Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene WT1, Gene, 167, 239, 10.1016/0378-1119(95)00645-1 Webster, 1997, Differential effects of Wilms' tumor WT1 splice variants on the insulin receptor promoter, Biochem. Mol. Med., 62, 139, 10.1006/bmme.1997.2648 Werner, 1993, Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms' tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms' tumor gene product, Proc. Natl. Acad. Sci. USA, 90, 5828, 10.1073/pnas.90.12.5828 Werner, 1994, Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site, J. Biol. Chem., 269, 12577, 10.1016/S0021-9258(18)99914-X Werner, 1995, Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression, Mol. Cell. Biol., 15, 3516, 10.1128/MCB.15.7.3516 Werner, 1996, Molecular determinants of mammalian sex, Trends Biochem. Sci., 21, 302 Yang, 1998, p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities, Mol. Cell, 2, 305, 10.1016/S1097-2765(00)80275-0 Yang, 1999, p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development, Nature, 398, 714, 10.1038/19539 Yang, 1999, WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis, Am. J. Pathol., 154, 181, 10.1016/S0002-9440(10)65264-9 Ye, 1996, Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation, EMBO J., 15, 5606, 10.1002/j.1460-2075.1996.tb00945.x Zanaria, 1994, An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita, Nature, 372, 635, 10.1038/372635a0 Zhan, 1998, Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding, Mol. Cell. Biol., 18, 2768, 10.1128/MCB.18.5.2768 Zhang, 1999, Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1, Anticancer Res., 19, 1641